发明名称 |
Tumour-associated peptides which bind to MHC molecules |
摘要 |
<p>Tumor-associated peptide having a 9-17 residue amino acid sequence from the groups SEQ ID-No. 1-577 from a given sequence protocol. The peptide has the ability to bond with a molecule of the human class I major histocompatibility complex (MHC) proteins. At least one amino acid is chemically modified, or at least one amino acid is deleted, or at least one amino acid is replaced by another amino acid with similar chemical characteristics. Tumor-associated peptide having a 9-17 residue amino acid sequence from the groups SEQ ID-No. 1-577 from a given sequence protocol. The peptide has the ability to bond with a molecule of the human class I major histocompatibility complex (MHC) proteins. At least one amino acid is chemically modified, or at least one amino acid is deleted, or at least one amino acid is replaced by another amino acid with similar chemical characteristics. The N and/or C terminal is available of at least one other amino acid. ACTIVITY : Cytostatic. No biological data is given. MECHANISM OF ACTION : None given.</p> |
申请公布号 |
SI2058323(T1) |
申请公布日期 |
2012.08.31 |
申请号 |
SI20050031543T |
申请日期 |
2005.05.24 |
申请人 |
IMMATICS BIOTECHNOLOGIES GMBH |
发明人 |
TRAUTWEIN CLAUDIA;RAMMENSEE HANS-GEORG;STEVANOVIC STEFAN;WEINSCHENK TONI |
分类号 |
A61K38/00;C07K7/06;C07K14/47 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|